InvestorsHub Logo
Followers 7
Posts 323
Boards Moderated 0
Alias Born 12/06/2008

Re: MedResCollab post# 200622

Tuesday, 07/09/2019 7:03:38 PM

Tuesday, July 09, 2019 7:03:38 PM

Post# of 426184
The point you seem to be so creatively avoiding is that Vascepa has been proven to work in an extensive and costly outcome study. No alternative can make the same claim, and regardless of price, what is important to a patient that is making a life or death decision about which drug to take, is it approved by the FDA? ..has it been proven to work?...what are the side affects? and how do I get some? ...not how can I save a couple nickels taking something that may or may not work and if it doesn't I die.

Further you really believe that a penny stock which hasn't even completed phase 3 yet, never mind an outcome study that will likely be required, is a threat to Amarin? Really, get a grip. A badly administered comparison study for bragging rights has no scientific validity what so ever.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News